COIOSDeep risk insights through multi-disciplinary research across the globe
a man with a white beard sitting in a gym
Item new Peer-reviewed Added

Between 15% and 49% of heart disease patients had clinically elevated cardiac anxiety

A review of 26 studies in 9,628 patients with cardiovascular disease found clinically elevated fear of cardiac sensations in 15% to 49%, varying with the questionnaire cut-off used.

The review covered 26 studies of adults with cardiovascular disease across eight countries, 9,628 patients in all, each measuring fear of cardiac sensations by questionnaire. Elevated fear ranged from 15% to 49%, and those patients also reported more depressive symptoms, poorer quality of life and less physical activity. In two prospective cohorts it independently predicted cardiac events and death after myocardial infarction, with hazard ratios of 1.30 to 1.59.

Why it is interesting: Fear of cardiac sensations, separable from general anxiety, tracked with events and death after myocardial infarction.

Source
European Journal of Preventive Cardiology, 28 September 2026
Paper
Cardiac Anxiety in Adults with Cardiovascular Disease: Prevalence, Predictors, and Implications for Cardiac Rehabilitation - A Systematic Review
Authors
Nwankwo HE, Ogunniyi KE, Okezue C, Divine D, Adebisi YA, Balogun T et al.
DOI
10.1093/eurjpc/zwag509
Type
Peer-reviewed article
Design
Systematic review with narrative synthesis, 26 studies, 9,628 enrolled patients across eight countries
Verdict
New finding
Driver
Heart and stroke
Driver
Mental health
Free full text
Free to read at the publisher
Attention
2 citations (Crossref) · as of 2026-10-31
Abstract — the authors' own words, CC BY

Background

Heart-focused anxiety (HFA) is a disease-specific construct characterised by fear of cardiac sensations, attentional hypervigilance, and behavioural avoidance of exertion. It is conceptually related to, but empirically separable from, generalized anxiety, but is rarely screened for in cardiac rehabilitation (CR). No prior systematic review has synthesised evidence on its prevalence, predictors, or CR implications. Methods

PubMed, CINAHL, PsycINFO, and the Cochrane Library were searched following PRISMA 2020 guidelines. Eligible studies measured HFA using the Cardiac Anxiety Questionnaire (CAQ) or Herzangstfragebogen (HAF-17) in adults with confirmed cardiovascular disease (CVD). Cross-sectional, cohort, validation, and intervention designs were eligible. Quality was appraised using NIH NHLBI Study Quality Assessment Tools and Cochrane Rob-2. Narrative synthesis was performed. This systematic review was prospectively registered on PROSPERO (CRD420261394690). Results

Twenty-six studies, with a combined enrolled sample of 9,628 patients across eight countries were included. Clinically elevated HFA ranged from 15% to 49% depending on the population, timing of assessment, and CAQ cut-off used. HFA was associated with depressive symptoms, illness perception, and impaired quality of life, and findings suggests a bidirectional relationship with physical inactivity. HFA independently predicted major adverse cardiac events and mortality post-MI in two prospective cohorts (HR range 1.30-1.59), with avoidance as the primary driver. Standard CR, specialised psychocardiological CR, device therapy, and early mobilisation were associated with reductions in HFA. Conclusions

HFA is prevalent across CVD diagnoses and was independently prognostic for adverse cardiovascular outcomes in two prospective cohorts. Several rehabilitation and psychological interventions were associated with HFA reductions, though the evidence remains largely observational. Routine CAQ screening at CR intake and targeted cognitive behavioural interventions for patients with elevated HFA warrant evaluation in future prospective studies.

Other drivers in Health today